124649-44-1

Upstream product

• 119874-37-2 3-O-(tert-butyldiphenylsilyl)-6-O-(4-methoxytetrahydropyran-4-yl)-1,2:4,5-di-O-isopropylidene-D-myo-inositol 
• 124648-22-2 3-O-(tert-butyldiphenylsilyl)-1,2:4,5-di-O-isopropylidene-D-myo-inositol 
• 119874-35-0 1⁽³⁾-O-(tert-butyldiphenylsilyl)-2,3⁽¹⁾:5,6⁽⁴⁾-di-O-isopropylidene-D-myo-inositol 
• 119874-36-1 3-O-(tert-butyldiphenylsilyl)-6-O-camphanyl-1,2:4,5-di-O-isopropylidene-D-myo-inositol 
• 17327-22-9 4-methoxy-2,6-dihydropyran 

Downstream Products

• 119874-40-7 1,2:4,5-di-O-isopropylidene-6-O-(4-methoxytetrahydropyran-4-yl)-D-myo-inositol 3-(2,3-di-O-hexadecanoyl-sn-glycer-1-yl phenyl phosphate) 
• 119874-40-7 1,2:4,5-di-O-isopropylidene-6-O-(4-methoxytetrahydropyran-4-yl)-D-myo-inositol 3-(1,2-di-O-hexadecanoyl-sn-glycer-3-yl phenyl phosphate) 

Relevant academic research and scientific papers

Total synthesis of the four stereoisomers of dihexadecanoyl phosphatidylinositol and the substrate stereospecificity of human erythrocyte membrane phosphatidylinositol 4-kinase

A new and convenient method for the preparation of the four stereoisomers of dihexadecanoyl phosphatidylinositol has been developed. An enantiomeric pair of acid-labile, pentaprotected myo-inositol building blocks was synthesized in high yield and coupled